In a regulatory filing, Ken Myszkowski notified Arrowhead (ARWR) of his decision to retire as CFO of the company, effective as of May 13. Myszkowski has served as the company’s CFO since 2009. The company said Myszkowski’s decision to retire was not the result of any disagreement with the company. Following the effective date, Myszkowski will serve as an employee adviser and provide transition services, as requested by the company, to facilitate an effective transition of his job responsibilities to his successor, until January 31, 2026. The company determined that it would appoint Daniel Apel to serve as CFO of the company. Apel joins the company from Walgreens Boots Alliance (WBA), where he served as global head of financial planning and analysis from 2019 through 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARWR:
- Aldeyra, Rocket, Westinghouse, Arrowhead, Sonos: Stock Shakeup!
- Arrowhead Pharmaceuticals’ ARO-C3: Promising Early Data with Hold Rating Amid Competitive Landscape
- Arrowhead data supports blockbuster potential of ARO-C3, says H.C. Wainwright
- Buy Rating for Arrowhead Pharmaceuticals Driven by Promising ARO-C3 Trial Results and Strategic Pipeline Advancements
- Arrowhead announces topline results from ARO-C3 trial